This site is for US healthcare professionals to provide online access to current, accurate, scientific information about our products. It is prepared by Janssen Medical Information and is not intended for promotional purposes, nor for medical advice.

  1. Home
  3. Selected Announcement

XARELTO® (rivaroxaban) Dear Healthcare Professional Letter, November 2019

A Dear Healthcare Professional Letter was issued for XARELTO® (rivaroxaban) in November 2019.

Please view the full Prescribing Information, including BOXED WARNING, for XARELTO® (rivaroxaban).

For product-related questions, please call our contact center at 1-800-Janssen (1-800-526-7736), or email your Medical Information Request and a response will be provided promptly.